⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 14, 2024Open Access

Supplementary figure S5 from Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer

Nilesh Gardi Rohan Chaubal Pallavi Parab Sunil Pachakar Suyash Kulkarni Tanuja Shet Shalaka Joshi Yogesh Kembhavi Pratik Chandrani Jelmar Quist Pradnya Kowtal Anita Grigoriadis Rajiv Sarin Raman Govindarajan Sudeep Gupta

View Full Paper

Ask AI

Bookmark

Share

Abstract

This figure shows the SGOL score for all patient samples with clinically relevant genes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gardi et al. (2024) studied this question.

synapsesocial.com/papers/68e7940ab6db643587704ddf https://doi.org/10.1158/2767-9764.25219016

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary figure S5 from Natural History of Germline <i>BRCA1</i> Mutated and <i>BRCA</i> Wild-type Triple-negative Breast Cancer2024
2Supplementary figure S1 from Natural History of Germline <i>BRCA1</i> Mutated and <i>BRCA</i> Wild-type Triple-negative Breast Cancer2024
3Supplementary figure S1 from Natural History of Germline <i>BRCA1</i> Mutated and <i>BRCA</i> Wild-type Triple-negative Breast Cancer2024
4Supplementary figure S4 from Natural History of Germline <i>BRCA1</i> Mutated and <i>BRCA</i> Wild-type Triple-negative Breast Cancer2024
5Supplementary figure S4 from Natural History of Germline <i>BRCA1</i> Mutated and <i>BRCA</i> Wild-type Triple-negative Breast Cancer2024